These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20879650)

  • 1. HPV modulation of host immune responses.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Meyerov R; Lemmer J
    SADJ; 2010 Jul; 65(6):266-8. PubMed ID: 20879650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of human papillomaviruses with the host immune system: a well evolved relationship.
    Frazer IH
    Virology; 2009 Feb; 384(2):410-4. PubMed ID: 18986661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
    Sheu BC; Chang WC; Lin HH; Chow SN; Huang SC
    J Obstet Gynaecol Res; 2007 Apr; 33(2):103-13. PubMed ID: 17441881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to human papillomavirus.
    Stanley M
    Vaccine; 2006 Mar; 24 Suppl 1():S16-22. PubMed ID: 16219398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the immune system in anogenital human papillomavirus.
    Frazer IH
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S5-7. PubMed ID: 9842093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The host response to lesions induced by human papillomavirus.
    Stanley M; Coleman N; Chambers M
    Ciba Found Symp; 1994; 187():21-32; discussion 32-44. PubMed ID: 7796671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic response to (pre)neoplastic cervical lesions associated with human papillomavirus].
    Delvenne P
    Bull Mem Acad R Med Belg; 2005; 160(5-6):287-93. PubMed ID: 16465783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to human papilloma viruses.
    Stanley MA
    Indian J Med Res; 2009 Sep; 130(3):266-76. PubMed ID: 19901436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunity of the female genital tract mucosa and mechanisms of papillomavirus evasion].
    Riethmuller D; Seilles E
    J Gynecol Obstet Biol Reprod (Paris); 2000 Dec; 29(8):729-740. PubMed ID: 11139708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How the bovine viral diarrhea virus outwits the immune system].
    Peterhans E; Jungi TW; Schweizer M
    Dtsch Tierarztl Wochenschr; 2006 Apr; 113(4):124-9. PubMed ID: 16716045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathobiology and mechanisms of infection of HPV.
    Wood NH; Khammissa RA; Chikte UM; Meyerov R; Lemmer J; Feller L
    SADJ; 2010 Apr; 65(3):124-6. PubMed ID: 20496845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host responses to infection with human papillomavirus.
    Stanley MA; Sterling JC
    Curr Probl Dermatol; 2014; 45():58-74. PubMed ID: 24643178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermotropism of T cells correlates with intercellular adhesion molecule (ICAM1) expression in human papillomavirus (HPV)-induced lesions.
    Viac J; Chardonnet Y; Euvrard S; Schmitt D
    J Pathol; 1992 Nov; 168(3):301-6. PubMed ID: 1361527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host immune responses to cervical cancer.
    Patel S; Chiplunkar S
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):54-9. PubMed ID: 19125004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
    Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL
    Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination.
    Stern PL
    J Clin Virol; 2005 Mar; 32 Suppl 1():S72-81. PubMed ID: 15753015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV induced cervical carcinogenesis: molecular basis and vaccine development.
    Kaufmann AM; Backsch C; Schneider A; Dürst M
    Zentralbl Gynakol; 2002 Nov; 124(11):511-24. PubMed ID: 12796844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
    Pinto LA; Edwards J; Castle PE; Harro CD; Lowy DR; Schiller JT; Wallace D; Kopp W; Adelsberger JW; Baseler MW; Berzofsky JA; Hildesheim A
    J Infect Dis; 2003 Jul; 188(2):327-38. PubMed ID: 12854090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.
    Baldwin PJ; van der Burg SH; Boswell CM; Offringa R; Hickling JK; Dobson J; Roberts JS; Latimer JA; Moseley RP; Coleman N; Stanley MA; Sterling JC
    Clin Cancer Res; 2003 Nov; 9(14):5205-13. PubMed ID: 14614000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.